The Toxicologist and Delirium: Flumazenil as a Diagnostic and Therapeutic Tool for Delirium During the Course of Alcohol Withdrawal

被引：0

作者：

Philip W Moore

Michelle A Hieger

J Ward Donovan

机构：

[1] Penn State University College of Medicine,

[2] Virginia Commonwealth University,undefined

来源：

关键词：

Hepatic Encephalopathy; Flumazenil; Ammonia Level; Alcohol Withdrawal; Therapeutic Tool;

D O I：

10.1007/s13181-014-0434-z

中图分类号：

学科分类号：

摘要：

引用

页码：436 / 437

页数：1

共 39 条

[1]

Lat I(2009)The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients Crit Care Med 37 1898-905

[2]

McMillian W(2014)Delirium in the cardiovascular intensive care unit: exploring modifiable risk factors Crit Care Med 41 405-13

[3]

Taylor S(2006)Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients Anesthesiology 104 21-6

[4]

Janzen JM(2008)Delirium in the acute care setting: characteristics, diagnosis and treatment Crit Care Clin 24 657-722

[5]

Papadopoulos S(1996)Risk factors for delirium tremens development J Gen Intern Med 11 410-4

[6]

Korth L(2014)Alcohol withdrawal and flumazenil: Not for the faint of heart J Med Toxicol 10 123-5

[7]

Ehtisham A(2008)Substance abuse and withdrawal in the critical care setting Crit Care Clin 24 767-88

[8]

Nold J(undefined)undefined undefined undefined undefined-undefined

[9]

Agarwal S(undefined)undefined undefined undefined undefined-undefined

[10]

Azocar R(undefined)undefined undefined undefined undefined-undefined